Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Haemonetics Corporation (HAE)

NYSE - NYSE Delayed Price. Currency in USD
Visitors trend2W10W9M
77.42+1.34 (+1.76%)
At close: 04:00PM EDT
77.42 0.00 (0.00%)
After hours: 05:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Williams %R

Williams %R

Performance Outlook
Previous Close76.08
Open75.35
Bid77.15 x 800
Ask84.00 x 800
Day's Range75.35 - 77.48
52 Week Range48.67 - 91.39
Volume303,119
Avg. Volume410,260
Market Cap3.906B
Beta (5Y Monthly)0.42
PE Ratio (TTM)42.08
EPS (TTM)1.84
Earnings DateMay 08, 2023 - May 12, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est100.86
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-16% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for HAE

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Haemonetics Corporation
    HAE: Raising target price to $81.00HAEMONETICS CORP/MASS has an Investment Rating of HOLD; a target price of $81.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Rating
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
Advertisement
Advertisement